Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
27.15
-0.17 (-0.62%)
At close: Dec 31, 2025, 4:00 PM EST
27.68
+0.53 (1.95%)
After-hours: Dec 31, 2025, 7:40 PM EST
Upstream Bio Stock Forecast
Stock Price Forecast
The 3 analysts that cover Upstream Bio stock have a consensus rating of "Strong Buy" and an average price target of $46, which forecasts a 69.43% increase in the stock price over the next year. The lowest target is $40 and the highest is $51.
Price Target: $46 (+69.43%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Upstream Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Initiates $51 | Buy | Initiates | $51 | +87.85% | Dec 18, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $40 | Buy | Initiates | $40 | +47.33% | Nov 18, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +73.11% | Oct 14, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +39.96% | Nov 5, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
Financial Forecast
Revenue This Year
2.77M
from 2.37M
Increased by 16.92%
Revenue Next Year
1.15M
from 2.77M
Decreased by -58.39%
EPS This Year
-2.59
from -5.58
EPS Next Year
-2.98
from -2.59
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.2M | 3.0M | ||||
| Avg | 2.8M | 1.2M | ||||
| Low | 2.1M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 32.9% | 9.9% | ||||
| Avg | 16.9% | -58.4% | ||||
| Low | -9.5% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.55 | -2.71 | ||||
| Avg | -2.59 | -2.98 | ||||
| Low | -2.72 | -3.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.